Of obesity on the health hazards of obesity is not only an independent disease

The most appropriate competition tactic for meizitang is to prove its effect.  Animal studies have shown that physical activity can promote the occurrence of obesity through opposite effects on food intake and, although the food intake with the energy consumption increases, but when physical activity to a minimum level of food intake and disproportionately reduced; obstructing the activities actually increase food intake for some people. 3 to adjust decided to pregnancy factor is the main determinant of obesity in some women. While most women in 1 year after childbirth, weight gain very little, but about 15% of women in each pregnancy 9kg as much as six babies and during childhood.
Further market investigation show that the target consumers of meizitang are the office ladies. Some severe obesity, even in the adult period, the increase in the volume of fat cells and adipose tissue to make it easy to get obesity. this increase of fat cells in obese people can produce five times more than normal weight people. diet only reduced the size of fat cells, but not to reduce the number of fat cells. Therefore, adipose tissue cell proliferation through each cell lipid content, a significant depletion can down to normal weight. depletion and membrane the development and changes on their ability to reduce body weight to determine a biological limit, and may explain why they are difficult to be reduced to normal body weight.
Of obesity on the health hazards of obesity is not only an independent disease, but also close and some other diseases related to the following table is WHO reported in obese patients with related diseases relative risk (Table 3). Office ladies are the most potential targets of meizitang products. Common obesity-related diseases relative risk of moderate to increase substantially increased (relative risk> 3) increased slightly (relative risk l ~ 2) cancer (in postmenopausal women with breast cancer, endometrial cancer and colon cancer) (relative risk 2-3) diabetes mellitus (type 2) with coronary artery disease gallbladder disease, high blood pressure Health osteoarthritis.
 (Knee reproductive hormones, abnormal lipid and hip abnormal insulin resistance difficulty breathing sleep apnea, polycystic ovary syndrome, hyperuricemia / gout reproductive function to reduce lower back pain caused by obesity increase the anesthetic risk and the mother of obesity-related birth defects' treatment of sources: WHO obesity treatment guidelines 1.3.4-obesity treatment for obesity is a chronic, recurrent, need long-term treatment of diseases and clinical studies have shown that: a lot of unhealthy weight reduction in a short time and easy rebound. the pursuit of so-called ideal weight is not realistic. Office workers pay more attention to their personal image, so most of them will choose meizitang products.
Moderate weight loss (5% of the original reduction of body weight to 10 Yo can significantly improve obesity-related comorbidity. the treatment of obesity 7 primary goal should be to: (1) by at least 5% of body weight, which is enough to bring the magnitude of the health benefits of weight loss: ② prevent weight rebound, or as much as possible to reduce the magnitude of the rebound; ③ prevent the occurrence of comorbidity or improve with the onset of the disease; ④ improve the quality of life and weight control program using four kinds of therapy : diet and nutrition counseling, behavioral therapy, medication and surgery. On the top of the list of meizitang products are those safe ones.